Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Advanced gynecologic cancers have historically lacked effective treatment options. Recently, immune checkpoint inhibitors (ICIs) have been approved by the US Food and Drug Administration for the treatment of cervical cancer and endometrial cancer, offering durable responses for some patients. In add...
Saved in:
Main Authors: | Anne Mills, Leisha A Emens, Mary L Disis, Kunle Odunsi, John B Liao, Tyler Curiel, Margaret Gatti-Mays, Amir Jazaeri, Emese Zsiros, Marcus O Butler, Jyoti Bajpai, Katherine C Kurnit, Haider Mahdi, Laura Doherty, Claire F Friedman, Melissa A Geller, Sarah F Adams, Shelley A Dodt, Veena S John |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-06-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/6/e006624.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
by: Wu Helena T., et al.
Published: (2025-01-01) -
Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy
by: Razelle Kurzrock, et al.
Published: (2022-09-01) -
Emerging insights into intravital imaging, unraveling its role in cancer immunotherapy
by: Minfeng Yang, et al.
Published: (2025-02-01) -
Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
by: Dingtian Luo, et al.
Published: (2025-02-01) -
The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
by: Si Chen, et al.
Published: (2024-09-01)